Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Midatech Pharma Ads (MTP)

Midatech Pharma Ads (MTP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,753
  • Shares Outstanding, K 3,059
  • Annual Sales, $ 2,590 K
  • Annual Income, $ -20,060 K
  • 60-Month Beta 2.60
  • Price/Sales 0.69
  • Price/Cash Flow N/A
  • Price/Book 0.06
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 07/30/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.54 +6.11%
on 12/09/19
0.83 -30.63%
on 11/14/19
-0.25 (-30.56%)
since 11/13/19
3-Month
0.54 +6.11%
on 12/09/19
1.70 -66.29%
on 10/02/19
-0.68 (-54.16%)
since 09/13/19
52-Week
0.54 +6.11%
on 12/09/19
10.90 -94.74%
on 02/27/19
-1.33 (-69.84%)
since 12/13/18

Most Recent Stories

More News
Midatech Pharma announces confirmation of a â?¬2.6 million EU Grant for further clinical development of MTX110 for the treatment of Diffuse Intrinsic Pontine Glioma, a rare and fatal form of childhood brain cancer

Midatech Pharma PLC ("Midatech" or the "Company") (AIM:MTPH.L; Nasdaq:MTP), an R&D biotechnology company focused on delivering innovative oncology and rare disease products to patients, is pleased to announce...

LNSTY : 24.3600 (+4.98%)
MTP : 0.57 (-2.05%)
Midatech Pharma PLC Announces Closing of US$3.0m Registered Direct Offering

Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), an R&D biotechnology company focused on delivering innovative oncology and rare disease products to patients, today announced the closing of its previously...

LNSTY : 24.3600 (+4.98%)
MTP : 0.57 (-2.05%)
Artificial Saliva Market By Current Industry Status,Growth Opportunities, Top Key Players, Target Audience And Forecast To 2022

This report studies Artificial Saliva in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions,...

GSK : 45.98 (+0.11%)
MTP : 0.57 (-2.05%)
VRX.TO : 30.80 (-3.33%)
Artificial Saliva Market 2018 Size, Global Trends, Comprehensive Research Study, Development Status, Opportunities, Future Plans, Competitive Landscape and Growth by Forecast 2025

The global Artificial Saliva market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.This report focuses on Artificial Saliva...

GSK : 45.98 (+0.11%)
MTP : 0.57 (-2.05%)
VRX.TO : 30.80 (-3.33%)
Biotech Brief: Reports Forecast Continued Rise in Revenues for Diabetic Ulcer Treatment Market

According to a report from Grand View Research, the global diabetic foot ulcer treatment market size is expected to reach a value of USD 6.82 billion by 2025, according to a new report by Grand View Research,...

HOTH : 4.45 (-4.18%)
MTP : 0.57 (-2.05%)
TEVA : 9.64 (-1.63%)
ACST : 2.04 (+16.57%)
ACST.VN : 2.680 (+16.02%)
OTLK : 1.24 (+9.73%)
Thinking about buying stock in Aurora Cannabis, Cleveland-Cliffs, Crowdstrike, General Electric, or Midatech Pharma?

InvestorsObserver issues critical PriceWatch Alerts for ACB, CLF, CRWD, GE, and MTP.

ACBFF : 8.6900 (-12.80%)
CLF : 8.62 (-2.71%)
GE : 11.34 (-0.87%)
MTP : 0.57 (-2.05%)
Midatech Pharma US, Inc. Announces Corporate Name Change To Fortovia Therapeutics And Appointment Of New CEO And CFO

Midatech Pharma US, Inc., an oncology supportive care specialty pharmaceutical company dedicated to helping patients manage cancer symptoms and treatment-related side effects, announced today that it has...

MTP : 0.57 (-2.05%)
Thinking about buying stock in Anadarko Petroleum Corp., Facebook Inc., Microsoft Corp., Midatech Pharma, or New Age Beverages Corp.?

InvestorsObserver issues critical PriceWatch Alerts for APC, FB, MSFT, MTP, and NBEV.

APC : 72.77 (+0.78%)
FB : 194.11 (-1.34%)
MSFT : 154.53 (+0.84%)
MTP : 0.57 (-2.05%)
NBEV : 1.90 (-1.04%)
Thinking about buying stock in Aceto, Canopy Growth Corp., Frontier Communications Corp., Midatech Pharma or Sea Ltd?

InvestorsObserver issues critical PriceWatch Alerts for ACET, CGC, FTR, MTP, and SE.

ACET : 0.13 (-23.67%)
FTR : 0.68 (+3.27%)
MTP : 0.57 (-2.05%)
SE : 36.80 (-1.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade MTP with:

Business Summary

Midatech Pharma Plc is focused on the discovery and development of pharmaceutical products of nanomedicine. The Company's product candidates, which are in clinical and pre-clinical development, are Transbuccal Insulin, glucagon-like-peptide, GLP-1/Insulin Combination, Q-Exenatide and Q-Octreotide. Midatech...

See More

Key Turning Points

2nd Resistance Point 0.62
1st Resistance Point 0.59
Last Price 0.57
1st Support Level 0.56
2nd Support Level 0.54

See More

52-Week High 10.90
Fibonacci 61.8% 6.94
Fibonacci 50% 5.72
Fibonacci 38.2% 4.50
Last Price 0.57
52-Week Low 0.54

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar